NICVD to Introduce Advanced Cardiac Program
NICVD has approved plans for an advanced heart failure program using Left Ventricular Assist Device technology. It will also prepare for a future heart transplant program.
The decisions came during the 85th NICVD Governing Body meeting. Sindh Chief Minister Syed Murad Ali Shah chaired the meeting at the Chief Minister’s House.
The chief minister said his government remains committed to quality cardiac care. He called NICVD a flagship healthcare institution and national asset.
Advanced Heart Failure Care
Murad directed NICVD to work with medical institutions in Pakistan and abroad. The goal is to secure technical support, training, and expertise.
An LVAD can support patients with severe heart failure when their heart cannot pump enough blood. Therefore, this service could offer another option for eligible patients.
NICVD also plans to build expertise for a future heart transplant program. Officials will need preparation, training, and specialist support before such services begin.
Expanding Specialized Services
The governing body also reviewed NICVD’s performance during 2025. Officials reported many cardiac procedures, surgeries, and emergency consultations.
NICVD Karachi treated more than 1.32 million patients from outside Sindh between 2019 and 2025. Patients came from Balochistan, Punjab, Khyber Pakhtunkhwa, AJK, and Gilgit-Baltistan.
As a result, the institute continues to serve patients from across Pakistan. The figures show growing demand for specialized cardiac services.
Strengthening Cardiac Expertise
The governing body approved the voluntary appointment of US-based cardiologist Prof Javed Suleman. He will serve as Professor of Cardiology and Medical Director at NICVD.
The appointment carries no financial liability for NICVD or the Sindh government. The chief minister directed management to complete projects on schedule.
Murad reaffirmed government support for expanding healthcare access. With stronger expertise and advanced technology, NICVD aims to improve care for patients with serious heart conditions for all patients.
